Status | Study |
Recruiting |
Study Name: Exercise in Genetic Cardiovascular Conditions Condition: Hypertrophic Cardiomyopathy Long QT Syndrome Date: 2015-06-10 |
Completed |
Study Name: Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function Condition: Long QT Syndrome Date: 2015-05-08 Interventions: Drug: Eleclazine Eleclazine tablets administered orally in morning with food |
Recruiting |
Study Name: Genetics of QT Prolongation With Antiarrhythmics Condition: Long QT Syndrome Drug Toxicity Date: 2015-05-05 Interventions: Drug: Dofetilide and/or sotalol This is an observational study of patients receiving Dofetilide and/or s |
Recruiting |
Study Name: Long QT Syndrome Screening in Newborns Condition: Long QT Syndrome Date: 2015-04-01 Interventions: Device: QTScreen ECG Recorder Subjects will be randomly assigned to the: Parents Performing ECG (PPE) gr |
Completed |
Study Name: Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function Condition: Long QT Syndrome Date: 2015-03-11 Interventions: Drug: Eleclazine Eleclazine tablets administered orally |
Completed |
Study Name: Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults Condition: Long QT Syndrome Date: 2015-02-13 Interventions: Drug: GS-6615 GS-6615 tablets |
Terminated |
Study Name: Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3 Condition: Long QT Syndrome Type 3 Date: 2014-11-21 Interventions: Drug: Eleclazine Eleclazine ta |
Recruiting |
Study Name: The Canadian National Long QT Syndrome Registry Condition: Long QT Syndrome Date: 2014-11-13 |
Recruiting |
Study Name: Long QT and Hearing Loss Registry Condition: Sensorineural Hearing Loss Long QT Syndrome Date: 2014-03-06 |
Completed |
Study Name: QT-prolongation in Psychiatric Hospitals Condition: QT-prolongation Date: 2014-01-21 Interventions: Drug: drugs linked with QT-prolongation all the drugs that are mentioned in the lists of QT-prolonging d |